Home > Newsletters > Devices & Diagnostics Letter > FDA Regulatory Affairs Office Restructured to Respond to Growing Industry Globalization
Devices & Diagnostics Letter
Sept. 24, 2012 | Vol. 39 No. 38
FDA Regulatory Affairs Office Restructured to Respond to Growing Industry Globalization
The FDA is planning to reorganize its Office of Regulatory Affairs (ORA), including creating new offices and reorganizing others, as it takes steps to dissolve cumbersome domestic and international distinctions and keep pace with increasingly global operations.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.